Keyphrases
Cystic Fibrosis
100%
Cystic Fibrosis Foundation
44%
Diabetes
42%
Consensus Statement
28%
Lung Transplantation
28%
Weight Gain
21%
Hypoglycemia
21%
Obesity
16%
Endocrinology
16%
Cardiometabolic Risk
15%
Energy Balance
14%
Cystic Fibrosis-related Diabetes
14%
Male Reproductive Health
14%
Adult Patients
14%
Severe Hypoglycemia
14%
Weight Parameter
14%
Hypoglycemia Unawareness
14%
Overweight or Obesity
14%
Nutritional Considerations
14%
Emerging Treatments
14%
Metabolic Parameters
14%
Ventricular Arrhythmia
14%
Lung Function
14%
Counterregulation
14%
Forced Expiratory Volume in 1 Second (FEV1)
14%
Elexacaftor-tezacaftor-ivacaftor
14%
Recurrent Hypoglycemia
14%
Position Paper
14%
High Risk
14%
Liver
14%
Pernicious Anemia
14%
Gastric Pathology
14%
Autoimmune Disease
14%
Lipid-lowering
14%
Chronic Kidney Disease
14%
Repeated Testing
14%
Clostridium Difficile Infection
14%
Test Sensitivity
14%
Pseudo-outbreak
14%
Perceived Prevalence
14%
Comorbidity
8%
Cardiovascular Risk
8%
Cardiometabolic Disease
8%
Insulin Deficiency
7%
Insulin Resistance
7%
BMI Classification
7%
Body Mass Index
6%
Glycemic Control
6%
Toxin Assay
6%
Stomach Lesions
6%
Medicine and Dentistry
Cystic Fibrosis
95%
Lung Transplantation
28%
Patient with Cystic Fibrosis
23%
Body Mass Index
20%
Prevalence
16%
Cardiometabolic Risk
15%
Obesity
15%
Ivacaftor
14%
Male Reproductive Health
14%
Diabetes
14%
Body Weight
14%
Energy Balance
14%
Tezacaftor
14%
Sensitivity and Specificity
14%
Clostridium Difficile Infection
14%
Pernicious Anemia
14%
Autoimmune Disease
14%
Lung
14%
Resting Energy Expenditure
9%
Endocrinology
9%
Insulin Resistance
8%
Liver Disease
8%
Blood Pressure
7%
Comorbidity
7%
Stomach Lesion
6%
Esophagogastroduodenoscopy
6%
Glucose Tolerance
5%
Nutrition
5%